Your session is about to expire
← Back to Search
Robot + Active Learning Program(RT-ALPS) for Stroke
Study Summary
This trial will study the effects of robot-assisted therapy on post-stroke patients' ability to use their affected arm in every day activities.
- Stroke
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the principal aims of this trial?
"This trial has two main objectives to assess over a period of around 10 weeks: (1) Alterations in Fugl-Meyer Assessment scores and (2) Modifications in Confidence in Arm and Hand Movement Scale. Secondary goals include shifts from the initial Home-based Accelerometry readings, as measured by GENEActiv sensors worn for 72 hours on both wrists at each assessment point; along with changes recorded via Wolf Motor Function Test Time assessments which can take up to 2 minutes per task, scored on a 6-point scale."
How many participants have been allowed to enroll in this experiment?
"Correct. According to clinicaltrials.gov, this investigation is still in search of participants and was first posted on June 6th 2019 with its most recent update taking place on May 26th 2022. This requires 15 people to be recruited from two distinct medical sites."
Is this experiment presently accepting new participants?
"Affirmative, clinicaltrials.gov indicates that this study is in the process of recruiting patients. Published on June 6th 2019 and last modified on May 26th 2022, the research aims to select 15 participants from 2 different sites."
Share this study with friends
Copy Link
Messenger